St Jones2022-08-10T16:01:11+00:00August 10th, 2022|Comments Off on Off-Target Effects of CRISPR-Cas9 Gene Editing in Human Hematopoietic Stem and Progenitor Cells
St Jones2022-08-10T15:54:57+00:00August 10th, 2022|Comments Off on Hematopoietic Stem Cell Electroporation for HDR-Mediated Correction of an X-Linked Blood Disorder
St Jones2022-06-06T21:59:54+00:00June 3rd, 2022|Comments Off on Which industry partner should I collaborate with? A scientists’ journey to implementing an innovative technology
St Jones2021-11-03T20:19:50+00:00November 3rd, 2021|Comments Off on Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models
St Jones2021-10-01T18:33:35+00:00September 30th, 2021|Comments Off on Efficient Electroporation of Neuronal Cells Using Synthetic Oligonucleotides: Identifying Duplex RNA and Antisense Oligonucleotide Activators of Human Frataxin Expression
St Jones2021-09-30T17:04:35+00:00September 30th, 2021|Comments Off on Electroporation Enables Oligonucleotide Delivery to Regulate Gene Expression in Friedrich’s Ataxia Patient-Derived Cells
St Jones2021-10-01T18:35:14+00:00November 11th, 2020|Comments Off on Genome-Wide Analysis of Off-Target CRISPR/Cas9 Activity in Single-Cell-Derived Human Hematopoietic Stem and Progenitor Cell Clones
ali2021-10-12T18:45:49+00:00May 16th, 2020|Comments Off on CRISPR-mediated Mutation Correction of Hematopoietic Stem Cells from Patients with X-linked Chronic Granulomatous Disease Using Non-Viral Cell Engineering